BioSpace News Archive

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, announced that it has received the second tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc.

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM)

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high-quality cannabis, announced today that it is offering all holders of 12% Senior Secured Convertible Debentures (the “Debentureholders”) a 12-month extension to the original November 22, 2020 maturity date (the “Extension Option”) that were originally issued on November 22, 2017 (the “Debentures”).

Lygos, Inc., a vertically integrated provider of safe and sustainable specialty ingredients, today announced the launch of Lygos CBx, a Lygos company and new website focused on delivering a wide range of high-quality, pure and sustainable non-plant-based cannabinoids

CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted cancers, announced that it has appointed Yunxiang Zhu, PhD, to the position of VP/Head of Global Research, overseeing all research and development and responsible for all drug development programs, from early discovery to the pre-clinical stage

HiFiBiO Therapeutics , a multinational biotherapeutics company with unique expertise in immune modulation and single-cell science, today announced the successful completion of the first cohort of the Phase I study ( NCT04590430 ) of HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment and prevent

PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD). This test is currently under review b

Promotion follows the Company’s achievement of key manufacturing milestones to support upcoming clinical trials

Tribe Public announced that Dietrich Stephan, Ph.D., Chief Executive Officer of NeuBase Therapeutics, Inc., a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, will present at Tribe Public’s Presentation and Q&A Webinar Event at 8:30 a.m. PDT / 11:30 a.m. EDT on Wednesday, October 28th, 2020.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, November 9, 2020 at 4:30 p.m. Eastern time.